Immunomodulatory treatment of relapsing-remitting multiple sclerosis - the ASSET (Avonex Assessment in Multiple Sclerosis Therapy) study, an observational study in 1354 patients

被引：0

|

作者：

Marziniak, M.

Graf, T.

Niemczyk, G.

Rehberg-Weber, K.

机构：

来源：

JOURNAL OF NEUROLOGY | 2012年 / 259卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：S113 / S114

页数：2

相关论文

共 50 条

[1] Immunomodulatory treatment of relapsing-remitting multiple sclerosis - the ASSET (AVONEX Assessment in Multiple Sclerosis-Therapy)-study, an observational study in 1343 patients
Marziniak, M.
Graf, T.
Niemczyk, G.
Rehberg-Weber, K.
Wernsdoerfer, C.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 236 - 236
[2] Comparable efficacy of immunomodulatory treatment of relapsing-remitting multiple sclerosis (RRMS) in daily practice: the ASSET (AVONEX assessment in multiple sclerosis therapy) study, an observational study in 1343 patients
Marziniak, M.
Taipale, K.
Rehberg-Weber, K.
Wernsdoerfer, C.
[J]. JOURNAL OF NEUROLOGY, 2013, 260 : S73 - S73
[3] Comparable efficacy of immunomodulatory treatment of relapsing remitting multiple sclerosis (RRMS) in daily practice: the ASSET (AVONEX assessment in multiple sclerosis-therapy) study, an observational study in 1343 patients
Marziniak, M.
Taipale, K.
Rehberg-Weber, K.
Wernsdoerfer, C.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 273 - 273
[4] Rationale and design of the prospective and retrospective observational study of Avonex and Rebif (PROOF) for the treatment of relapsing-remitting multiple sclerosis
Murray, TJ
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (01) : 25 - 30
[5] Reasons for switching immunomodulatory therapy in patients with relapsing-remitting multiple sclerosis
Popiel, Malgorzata
Bartosik-Psujek, Halina
[J]. AKTUALNOSCI NEUROLOGICZNE, 2021, 21 (01): : 3 - 8
[6] Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis
Etemadifar, M
Janghorbani, M
Shaygannejad, V
[J]. ACTA NEUROLOGICA SCANDINAVICA, 2006, 113 (05): : 283 - 287
[7] Comparison of Betaferon®, Avonex® and Rebif® in treatment of relapsing-remitting multiple sclerosis
Shaygannejad, V.
Etemadifar, M.
Fereshteh, A.
[J]. MULTIPLE SCLEROSIS, 2006, 12 : S200 - S200
[8] Comparison of immunomodulatory therapies in treatment of relapsing-remitting multiple sclerosis
Aydin Canturk, I.
Isik, N.
Unsal, A.
Arici, O.
Yildiz, N.
Candan, F.
[J]. MULTIPLE SCLEROSIS, 2006, 12 : S96 - S96
[9] A retrospective, observational study comparing the four available immunomodulatory treatments for relapsing-remitting multiple sclerosis
Carrá, A
Onaha, P
Sinay, V
Alvarez, F
Luetic, G
Bettinelli, R
San Pedro, E
Rodríguez, L
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2003, 10 (06) : 671 - 676
[10] Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study
Totaro, Rocco
Di Carmine, Caterina
Costantino, Gianfranco
Fantozzi, Roberta
Bellantonio, Paolo
Fuiani, Aurora
Mundi, Ciro
Ruggieri, Stefano
Marini, Carmine
Carolei, Antonio
[J]. MULTIPLE SCLEROSIS INTERNATIONAL, 2015, 2015

← 1 2 3 4 5 →